• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

SUI Group Increases Loan to Bluefin, Strengthening DeFi Ties

chest

SUI Group Holdings Limited has expanded its lending agreement with Bluefin, increasing the total loan to 6 million SUI to support Bluewater Labs' acquisition of Suilend.

user avatarLuis Flores

Sui Seal MPC Introduces Hidden Bids for Enhanced AI Trading Security

chest

Mysten Labs has introduced a feature in the Sui Seal MPC system that enables hidden bids for AI trading, enhancing security and reducing risks of frontrunning.

user avatarMaria Gutierrez

Mysten Labs Introduces Sui Seal MPC for Secure AI Transactions

chest

Mysten Labs has launched Sui Seal MPC on the Sui mainnet, enabling autonomous AI agents to execute onchain transactions securely without holding private keys.

user avatarArif Mukhtar

Chainlink Collaborates with Project Pangea to Revolutionize Cross-Border FX Settlements

chest

Chainlink partners with Project Pangea to enhance cross-border FX settlements, aiming to reduce settlement times from T2 to T0 using stablecoins by mid-2027.

user avatarDavid Robinson

SecondFi Suspends Services Due to Critical Wallet Flaw

chest

SecondFi has suspended its services due to a critical vulnerability in its wallet generation software that led to the theft of ADA.

user avatarAndrew Smith

Morgan Stanley's Proposed Solana Trust Filing Sparks Market Interest

chest

Morgan Stanley has amended its S1A filing for a proposed spot Solana Trust, focusing on fees and staking plans.

user avatarJacob Williams

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.